ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0999

Race, Payer, and Hospital Factors Are Associated with Post-primary Total Hip Arthroplasty Healthcare Utilization

Kranti Rumalla1, Sumanth Chandrupatla2 and Jasvinder Singh2, 1Northwestern School of Medicine, Chicago, IL, 2University of Alabama at Birmingham, Birmingham, AL

Meeting: ACR Convergence 2023

Keywords: Administrative Data, Arthroplasty, Health Services Research, race/ethnicity

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 13, 2023

Title: (0993–1012) Health Services Research Poster II

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Over 450,000 primary total hip arthroplasties (THA) are performed each year. One major indication for primary THA is the presence of osteoarthritis (OA). Patient characteristics, insurance payer status, and regional and hospital level factors can lead to disparities in outcomes and costs of primary THA in patients with OA. We aimed to examine the association of these factors to extended lengths of stay and increased hospital costs after primary THA.

Methods: We utilized the National Inpatient Sample (NIS) to identify patients with OA who underwent primary THA in 2019. Diagnoses and procedures were identified using the International Classification of Disease (ICD-10) codes. We stratified healthcare/resource utilization by the occurrence of an extended length of stay (eLOS) and the presence of an increased hospital charge (IHC), i.e., the upper quartile each outcome. Univariate and multivariable analyses compared patient-level, regional, and hospital characteristics associated with an eLOS or IHC. Predictive probabilities from multivariable analyses were used in Area Under the Curve (AUC) analysis.

Results: There were 424,555 patients with OA who underwent primary THA in 2019. Patient race/ethnicity, Medicaid or Medicare payer status, income, age/sex and nearly all regional, and hospital, characteristics were independently associated with eLOS (ROC C-statistic = 0.74). Significant independent predictors for IHC were race & ethnicity (p < 0.001), hospital region (p < 0.001), hospital location & teaching status (p < 0.001), and hospital control (p < 0.001). The ROC curve classifying IHC had a C-statistic of 0.76.

Conclusion: Patient race/ethnicity and insurance payer status are important determinants of longer LOS for primary THA hospitalizations in the US. Well-known geographical and hospital-level disparities are negatively associated with the outcomes and costs of primary THA in patients with OA. Policy and other interventions targeting these factors may help reduce utilization for elective THA.

Supporting image 1

Supporting image 2

Supporting image 3


Disclosures: K. Rumalla: None; S. Chandrupatla: None; J. Singh: Other, 2, 6, 11, 11, 12, Adaptimmune Therapeutics, GeoVax Labs, Pieris Pharmaceuticals, Enzolytics Inc., Seres Therapeutics, Tonix, Charlotte’s Web, 12, Atai life sciences, kintara therapeutics, Intelligent Biosolutions, Acumen pharmaceutical, TPT Global Tech, Vaxart pharmaceuticals, Atyu biopharma, 12, speaker’s bureau of Simply Speaking, other, 12, received institutional research support from Zimmer Biomet Holdings. JAS received food and beverage payments from Intuitive Surgical Inc./Philips Elec, Other, 12, Schipher, Crealta/Horizon, Medisys, Fidia, PK Med, Two labs Inc., Adept Field Solutions, Clinical Care options, Clearview healthcare partners, Putnam.

To cite this abstract in AMA style:

Rumalla K, Chandrupatla S, Singh J. Race, Payer, and Hospital Factors Are Associated with Post-primary Total Hip Arthroplasty Healthcare Utilization [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/race-payer-and-hospital-factors-are-associated-with-post-primary-total-hip-arthroplasty-healthcare-utilization/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/race-payer-and-hospital-factors-are-associated-with-post-primary-total-hip-arthroplasty-healthcare-utilization/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology